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What’s new? 
 Addressing many of the limitations of previous studies, our paper is one of the first 
European studies to quantify the excess health service use and costs independently 
attributable to diabetes. 
 After accounting for important determinants of health service use, diabetes was 
associated with substantial additional health service use and costs across the health 
system. Hospital admissions account for two-thirds of the cost burden.  
 We provide informative estimates for policy-makers, identifying the costs that can be 
directly targeted by diabetes prevention and management interventions and by 




Aims To estimate the health service use and direct healthcare costs attributable to diabetes 
using best available data and methods. 
Methods A nationally representative sample of adults aged ≥50 years was analysed 
(n=8107). Health service use in the previous 12 months included the number of general 
practitioner visits, outpatient department visits, hospital admissions, and accident and 
emergency department attendances. Multivariable negative binomial regression was used to 
estimate the associations between diabetes and frequency of visits. Average marginal effects 
were applied to unit costs for each health service and extrapolated to the total population, 
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Results The prevalence of diabetes was 8.0% (95% CI 7.4, 8.6). In fully adjusted models, 
diabetes was associated with additional health service use. Compared to those without 
diabetes, people with diabetes have, on average, 1.49 (95% CI 1.10, 1.88) additional general 
practitioner visits annually. Diabetes was associated with an 87% increase in outpatient visits, 
a 52% increase in hospital admissions and a 33% increase in accident and emergency 
department attendances (P<0.001). The incremental cost of this additional service use, 
nationally, is an estimated €88,894,421 annually, with hospital admissions accounting for 
67% of these costs. 
 
Conclusion Using robust methods, we identified substantially increased service use 
attributable to diabetes across the health system. Our findings highlight the urgent need to 
invest in the prevention and management of diabetes. 
 
Introduction 
The number of people with diabetes has increased fourfold in the past 35 years and it is now 
the seventh leading cause of years lived with disability worldwide [1,2]. The impact of 
diabetes on health systems and national economies is of growing concern. In 2015, the global 
cost of diabetes was estimated to be US$1.31 trillion, with direct medical costs accounting for 
two-thirds of the costs [3]. Increasing prevalence combined with rising per capita medical 
expenditure indicate that the burden of diabetes on health systems will continue to escalate 
[4]. An understanding of the health service use and related costs associated with diabetes is 
necessary to inform national policies and the allocation of scarce resources. It is also essential 
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Worldwide, there is a lack of accurate, comprehensive and comparable estimates of the health 
service use and costs attributable to diabetes [3]. This is largely attributable to the variation in 
methodologies employed [5].  Furthermore, the approach used affects the policy relevance of 
the estimates. There are three main methodological approaches: the sum-all medical 
approach; the disease-attributable approach; and incremental cost analysis. The most 
common method applied for estimating the cost of diabetes is the sum-all medical approach 
[5]. This method fails to identify service use attributable to diabetes and, thus, does not 
identify costs that can be avoided by diabetes prevention or management interventions. As a 
result, the sum-all medical approach does not provide meaningful estimates to inform policy 
decisions. Another common method used is the disease-attributable approach, whereby 
attributable fractions for conditions associated with diabetes are applied to health service use 
data to identify the proportion attributable to diabetes [5]. This method underestimates 
service use and the costs associated with diabetes because of its inability to capture use that 
does not appear directly attributable to diabetes [5,6]. For instance, mental health 
comorbidities in people with diabetes increase health service utilization [7]; however, 
because of its reliance on established quantifiable causal associations, disease-attributable 
methodology will not capture such excess service use.  
 
More recent studies adopt an incremental costing approach. This method identifies the 
incremental health service use and costs for people with diabetes compared to those without, 
therefore capturing all costs associated with diabetes. The incremental costing approach also 
allows consideration of other factors known to influence health service use, including age, 
sex, ethnicity, education, socio-economic status, health status and lifestyle factors [8]. Thus, 
it is possible to estimate health service use that is independently associated with diabetes 
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for valid and reliable country-level data [3]. The aim of the present study was to provide 
robust estimates of health service use and direct healthcare costs attributable to diabetes from 
a societal perspective by applying an incremental cost approach, with appropriate adjustment, 
using a nationally representative sample of a community-dwelling adults, aged ≥50 years, 




A cross-sectional analysis of data from the first wave of The Irish Longitudinal Study of 
Ageing (TILDA) was conducted. TILDA is a nationally representative prospective cohort 
study of community-dwelling adults aged ≥50 years in the Republic of Ireland [10]. The 
sampling frame used for TILDA was the Irish Geodirectory, a comprehensive and up-to-date 
list of all residential addresses in Ireland. A multistage probability sampling design was used, 
with each residential address in the country having an equal probability of selection [10]. 
Eligible addresses were defined as any household with a person aged ≥50 years. All 
household residents aged ≥50 years were eligible to participate in the study. The estimated 
number of eligible households was 10 129. Of these, 6282 households participated (response 
rate 62%) and 8175 individuals were recruited. Ethical approval was obtained from the 
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Data collection 
Data collection occurred between October 2009 and November 2011. Participants were 
visited in their home by trained interviewers, who used computer-assisted personal 
interviewing. This included detailed questions about sociodemographics, physical and mental 
health, self-reported doctor-diagnosis of chronic conditions and health service use.  
 
Variable definition 
The outcome of interest was self-reported health service use. Participants were asked about 
the frequency of visits to general practitioner (GP) services, outpatient department visits, 
hospital admissions and accident and emergency department (A&E) attendances in the past 
12 months. They were also asked whether they had attended any of the following ancillary 
state services in the 12 months preceding the survey: dietitian; chiropody; optician; public 
health or community nurse; or psychology/counselling services. Individuals were classified 
as having diabetes if they self-reported a previous doctor diagnosis of diabetes. To distinguish 
between people with Type 1 and Type 2 diabetes, we defined those who were aged <50 years 
at diabetes diagnosis and reported injecting insulin, but who were not taking oral 
hypoglycaemic agents, as having Type 1 diabetes. All others were classified as having Type 2 
diabetes. Participants who reported a doctor diagnosis of diabetes during the computer-
assisted personal interviewing were asked the question, ‘Has a doctor ever told you that you 
have any of the following conditions related to your diabetes?’. The conditions listed were: 
leg ulcer; protein in urine; lack of feeling and tingling pain in legs and feet due to nerve 
damage; damage to the back of the eye. Any participant who answered 'yes' to any of the 
above was considered to have a microvascular complication. Any participant who self-
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cardiac failure), stroke (cerebrovascular accident) and mini stroke (transient ischaemic attack) 
was considered to have macrovascular complications. Other variables of interest included age 
(in years), gender, marital status (yes/no), education (primary, secondary, third level), 
location (urban/rural), healthcare cover (means tested public health insurance, private health 
insurance, both, neither), self-reported health status (excellent, very good, good, fair, poor) 
and other chronic conditions deemed not to be associated with diabetes. These conditions 
were lung disease, asthma, arthritis, osteoporosis, cancer, Parkinson’s disease and peptic 
ulcer disease.  
 
Statistical analysis 
Health service utilization was compared across populations with and without diabetes. The 
differences in the proportion of people attending each health service was analysed using 
Pearson’s chi-squared test. An independent samples t-test was used to analyse the difference 
in the mean number of visits to each service. Logistic regression was used to model the 
association between diabetes and attendance at ancillary state services. Negative binomial 
regression models were used to analyse the association between diabetes and the frequency of 
health service use. Poisson, negative binomial, zero-inflated Poisson and zero-inflated 
negative binomial regression models were explored. Model selection was informed by 
Akaike Information Criterion and Bayesian Information Criterion statistics and by comparing 
predicted and observed probabilities, with negative binomial regression being selected as the 
most appropriate model (Appendix S1) [11]. Average marginal effects were calculated, 
providing an estimate of the excess number of visits/admissions attributable to diabetes on 
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margins dydx, in STATA. This calculates a predicted probability for each case with the fixed 
and observed values of variables, and then averages the predicted values [12].   
 
The Anderson framework for the societal and individual determinants of healthcare 
utilization was used to inform the selection of appropriate variables to include in the 
multivariable regression models, with the aim of identifying the independent effect of 
diabetes on health service use [13]. The Anderson framework categorizes determinants as 
either predisposing, enabling or need factors. Any variables that could potentially mediate the 
association between diabetes and health service use were omitted. Multivariable regression 
was used to first adjust for predisposing factors (age, gender and marital status), then 
enabling factors (education, healthcare cover and location) and finally need factors (other 
chronic conditions).  
 
Sampling weights were applied to all data analyses to adjust for differential non-response and 
to reduce the potential for participation or selection bias [10]. Complete data were available 
for 99.1% of the sample and so a complete case analysis was carried out. Analysis was 
carried out in STATA v.12 for windows (StataCorp, College Station, TX, USA) using the 
survey function (svy).  
Calculation of costs 
The average marginal effects for significant associations were applied to unit costs for the 
relevant health service. A societal perspective was adopted, applying average unit costs of 
€50 for a GP visit, €160 for an outpatient department visit, €5,030 for a hospital inpatient 
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costs were extrapolated to the total population with diabetes to calculate the incremental 
health service costs. The total population with diabetes was estimated by applying the 
prevalence of diabetes in the sample to the most recent Irish census figures (2016). Cost 
estimates are reported in Euro and US dollars (USD) and were inflated to represent costs for 
2016 using the Consumer Price Index (CPI) Inflation Calculator for Ireland [16]. To reflect 
uncertainty in the estimates of average unit costs, a sensitivity analysis was conducted 
whereby these estimates were varied by ± 20% [17].  
 
Results  
Of the 8107 participants included in the analysis, 51.9% were female and 41.5% were aged 
≥65 years. The prevalence of diabetes was 8.0% (95% CI 7.4, 8.6), only 11 participants had 
Type 1 diabetes. Among people with diabetes, 15.8% (95% CI 13.0, 19.2) reported a 
macrovascular complication, while 26.3% (95% CI 22.7, 30.3) reported a microvascular 
complication.  
 
There were significant differences between the population with and without diabetes (Table 
1). People with diabetes were older, included a lower proportion of women, lower levels of 
educational attainment and lower self-reported health status. They were also more likely to be 
covered by public health insurance. There was significantly higher service utilization among 
people with diabetes for all health services, except psychology/counselling services. Those 
with diabetes reported an average of 5.8 GP visits in the past 12 months compared with 3.8 
visits among those without diabetes (P<0.001). Of people with diabetes, 60.8% (95% CI 
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(95% CI 37.7, 40.5) of those without diabetes. A higher proportion of people with diabetes 
also reported being admitted to hospital in the previous 12 months [19.8% (95% CI 16.7, 
23.2)] than those without diabetes [12.4% (95% CI 11.6, 13.2)]. Similar variations were 
observed for A&E attendances, with 20.5% (95% CI 17.3, 24.1) of people with diabetes 
attending A&E compared with 14.9% (95% CI 14.0, 15.8) of people without diabetes. 
 
There were large statistically significant differences in the proportion of people attending all 
ancillary state services in the previous year between the two populations, other than 
attendance at a psychologist or counsellor (Table 1). The proportion of people with diabetes 
attending these services did not exceed 21%. Table 2 documents the adjusted odds ratios for 
attending ancillary state services for people with diabetes compared to those without. The 
odds of people with diabetes visiting a dietitian were 19.2 times those of people without 
diabetes (95% CI 12.4, 29.6). People with diabetes were four times more likely to visit a 
chiropodist than those without (95% CI 3.0, 5.5). Diabetes was also significantly associated 
with ~60% increased odds of attendance at an optician or public health nurse, with odds 
ratios of 1.58 (95% CI 1.27, 1.96) and 1.57 (95% CI 1.17, 2.10), respectively.  
 
The incidence rate ratios (IRRs) and average marginal effects from the multivariable negative 
binomial regression models are presented in Table 3. There were statistically significant 
positive associations between diabetes and the frequency of GP visits, outpatient department 
visits, hospital admissions and A&E attendances. Adjustment for important confounding 
variables resulted in an attenuation of the IRR point estimates. In the fully adjusted models, 
people with diabetes had a higher rate of GP visits, with an IRR of 1.39 (95% CI 1.29, 1.50). 
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Diabetes was associated with an 87% increase in outpatient department visits and a 52% 
increase in hospital admissions (P<0.001). A&E attendance was also associated with diabetes 
(IRR 1.33; 95% CI 1.06, 1.66). On average, 1.49 (95% CI 1.10, 1.88) additional GP visits 
were attributable to diabetes in a 12-month period and approximately one additional 
outpatient visit [0.97 (95% CI 0.73, 1.21)].    
 
The population-based cost estimates for the incremental health service use associated with 
diabetes are shown in Table 4. The total population in Ireland in 2016 aged ≥50 years was  
 
1 446 460. The prevalence of diabetes in this sample was applied, estimating that 115 717 
adults aged ≥50 years had diabetes  in Ireland. The incremental health service use associated 
with diabetes was estimated to cost €88,894,421 per annum. Hospital admissions accounted 
for the majority of this spending, costing an estimated €60,002,517. The results of the 
sensitivity analysis are shown in Table 5. By varying the unit cost estimates by ± 20%, the 
cost of the incremental health service use associated with diabetes fluctuated from 
€71,115,537 to €106,673,305. 
 
Discussion 
Using a large nationally representative population-based study, we have provided robust 
estimates of health service use and related costs attributable to diabetes. We identified 
substantial increased service use associated with diabetes across the health system. Because 
of the high costs of hospital admissions, hospitalization costs place the largest burden on the 
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Diabetes was associated with a 39% increase in GP visits and an 87% increase in outpatient 
department visits. This translated to an additional 1.49 GP visits on average per annum and 
approximately one additional outpatient visit. Because of the higher unit cost of outpatient 
visits, the associated costs were more than twice those of primary care costs. With ageing 
populations and the increasing burden of chronic disease, greater attention has been paid to 
coordinating patient care according to levels of disease complexity. There has been a shift 
towards multidisciplinary, shared management of complex cases of diabetes across primary 
and secondary care settings, and structured management of people with uncomplicated 
diabetes in primary care, with suitable organizational support [18]. The present findings 
suggest this shift in routine care settings could result in considerable cost savings.  
 
Diabetes diagnosis was associated with increased hospital admissions, in line with a number 
of international studies that document higher rates of hospitalizations in people with diabetes 
[19,20]. While many studies only take age and gender into consideration, the present findings 
add to the literature by indicating that, in a population-based sample, diabetes remains 
associated with a higher number of hospital admissions after controlling for a wide range of 
important potential confounders. Our analysis shows that diabetes was associated with a 52% 
higher number of admissions. Because of variations in study populations and methodological 
approaches, direct comparisons with previous studies are limited. One study conducted in 
Tayside, Scotland, reported a 100% higher rate of hospital admissions in people with diabetes 
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Almost 70% of the health service costs associated with diabetes resulted from hospital 
admissions. Numerous studies report hospital admissions as the main driver of costs 
associated with diabetes, and the present findings highlight the need to provide effective 
interventions for the management of diabetes and related complications [22,23]. Increased 
risk of hospitalization in people with diabetes is attributable to macrovascular and 
microvascular complications [19,24]. While significantly higher than the population without 
diabetes, it is concerning that less than one-quarter of people with diabetes reported attending 
ancillary state services, such as chiropody and dietetic services. A shortage of allied health 
professionals has previously been identified as a barrier to delivering diabetes care in Ireland 
[25]. International guidelines identify these services as part of routine care for people with 
diabetes [26]. Such services, specifically foot care services and dietetic interventions for 
people with diabetes, are effective in preventing complications and subsequently reducing 
healthcare expenditure [27]. While these services may be available privately, at a significant 
cost to the patient, it is imperative that such effective services are accessible to all people 
with diabetes.  
 
Addressing many of the limitations of previous studies, we provide robust estimates of health 
service utilization attributable to diabetes. By adopting an incremental approach, we ensured 
that any excess health service use attributable to diabetes was identified, not just the service 
use that appeared directly related to diabetes. For instance, this approach ensured that excess 
service use associated with mental health issues was captured in our results. A nationally 
representative sample provides an appropriate comparison group to calculate incremental use 
and costs, avoiding the overrepresentation of people with diabetes and diabetes-related 
complications. To date, studies have largely relied on hospital-based samples or 
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diabetes, we specifically address the issue of endogeneity [5]. The present study accounts for 
important confounding variables that have previously been recognized as predictors of 
service use, identifying the costs that can be independently attributed to diabetes [8]. The 
adjustment for such factors led to the attenuation of our estimates. Most incremental studies 
control for gender and age only, because of data availability constraints [3,5,24,28], and so 
may overestimate service use and costs attributable to diabetes. Furthermore, any variables 
identified as potential mediating factors were omitted from the analyses, ensuring that the 
findings were not an underestimation of the true association between diabetes and health 
service use. To date, the only nationally representative studies adopting the incremental 
costing approach and adjusting for additional factors were conducted in the USA [4,9].  
 
While we cannot infer causality because of the cross-sectional nature of the data, almost 90% 
of the cohort had attended the GP in the previous year. Thus, the potential for reverse 
causality, whereby those who attend the GP are more likely to be diagnosed with diabetes and 
diabetes-related complications, is reduced. Furthermore, <1% of the cohort had undiagnosed 
diabetes on the basis of HbA1c measurement [29]. While the reliance on self-report doctor 
diagnoses may potentially introduce misclassification bias and result in inaccurate estimates, 
evidence shows that self-report is a suitable measure for estimating the prevalence of chronic 
conditions including diabetes when compared to medical records [30].  Health service 
utilization is also based on self-report, introducing potential for measurement bias; however, 
recent studies suggest there is no evidence of differential recall bias according to 
demographics or health status [31]. This method is widely used in health services research. 
The data were weighted to adjust for differential non-response with the aim of minimizing the 
potential for selection bias and improving the representativeness of the findings; however, 
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with diabetes in community-dwelling adults aged ≥50 years and so do not represent costs for 
the total population. It is estimated that <1.6% of the adult population aged ≥50 years in 
Ireland are in long-term residential care [32].  It is also important to note that cost estimates 
are based on average unit costs per visit/admission. Diabetes-related admissions are more 
expensive and, as a result, our cost estimates are likely to be an underestimation of the true 
costs of hospital admissions [22]. The cost estimates also only refer to additional service use 
for GP and hospital services. As a result of data limitations, we were unable to calculate the 
costs associated with ancillary service use or community care. Although we took a societal 
perspective in calculating the associated costs, our estimates represent the direct medical 
costs and do not consider the indirect costs associated with excess health service use. The 
accuracy of our estimates could be improved in further research by applying the 
demonstrated methods to individual-level cost data. The challenge, however, is to find a data 
source with all the necessary information. In the absence of a unique identifier in Ireland, this 
was not possible.  
 
In conclusion, the present findings show that diabetes is associated with substantial additional 
health service use and costs, with hospital admissions accounting for more than two-thirds of 
the cost burden. We highlight areas for potential cost savings in the context of finite 
healthcare resources, such as a shift in routine management to primary care and improved 
access to effective ancillary services, such as foot care services and dietetic interventions 
[27]. We provide robust informative estimates for policy-makers by identifying additional 
health service use and costs that are attributable to diabetes. Effective interventions aimed 
specifically at both diabetes prevention and management therefore have the potential to have 
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Supporting information 
 
Additional Supporting Information may be found in the online version of this article:  
 
Appendix S1. Model diagnostics for the multivariable model. 
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Table 1  Characteristics of population by diabetes diagnosis 


























Rural residence, n  44  40  0.12 
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A&E attendance  
Attended in past year , n 
Mean (SD)  no. visits past year 
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  A&E, accident and emergency department; GP, general practitioner; TILDA,  The Irish Longitudinal Study of Ageing. 
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Table 2  Adjusted odds ratios for the association between diabetes diagnosis and ancillary 
service use in previous 12-month period 
 
*
Models adjusted for age, gender, marital status, urban/rural location, education, healthcare cover, chronic 
conditions.  
Ancillary service Adjusted odds ratio (95% CI)
* 
P 
Dietitian 19.2 (12.4, 29.6) <0.001 
Chiropody  4.06 (3.00, 5.50) <0.001 
Optician 1.58 (1.27, 1.96) <0.001 
Public health/community nurse 1.57 (1.17, 2.10) 0.003 
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Table 3 Multivariable negative binomial regression results 
Health 
service 
Model 1: Crude Model 2: Predisposing Model 3: Enabling Model 4: Need 
 IRR (95% CI) AME (95% CI) IRR (95% CI) AME (95% CI) IRR (95% CI) AME (95% CI) IRR (95% CI) AME (95% CI) 
GP visits 1.53 (1.42, 1.64) 
P<0.001 
1.99 (1.58, 2.40) 
P<0.001 
1.50 (1.38, 1.62) 
P<0.001 
1.88 (1.45, 2.32) 
P<0.001 
1.38 (1.28, 1.49) 
P<0.001 
1.46 (1.08, 1.84) 
P<0.001 
1.39 (1.29, 1.50) 
P<0.001 




1.93 (1.73, 2.17) 
P<0.001 
1.04 (0.81, 1.27) 
P<0.001 
1.91 (1.70, 2.14) 
P<0.001 
1.01 (0.79, 1.24) 
P<0.001 
1.77 (1.58, 1.99) 
P<0.001 
0.87 (0.65, 1.08) 
P<0.001 
1.87 (1.65, 2.11) 
P<0.001 




1.68 (1.35, 2.09) 
P<0.001 
0.12 (0.06, 0.19) 
P<0.001 
1.58 (1.26, 1.98)  
P<0.001 
0.11 (0.04, 0.17)  
P=0.001 
1.49 (1.20, 1.85) 
P<0.001 
0.09 (0.03, 0.15) 
P=0.002 
1.52 (1.21, 1.91) 
P<0.001 




1.42 (1.15, 1.77)  
P=0.001 
0.09 (0.03, 0.16)  
P=0.006 
1.41 (1.13, 1.77)  
P=0.002 
0.09 (0.02, 0.16)  
P=0.008 
1.34 (1.07, 1.68)  
P=0.01 
0.08 (0.01, 0.14)  
P=0.02 
1.33 (1.06, 1.66)  
P=0.01 
0.07 (0.01, 0.14) 
P=0.03  
 A&E, accident and emergency department; AME, average marginal effect; GP, general practitioner; IRR, incidence rate ratio.  
Model 1: crude association; Model 2: adjusted for age, gender, marital status; Model 3: adjusted for age, gender, marital status, education, healthcare cover, location; Model 4: adjusted for age, 
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Table 4  Total incremental health service costs attributable to diabetes 
Health service Direct costs  
(95% CI) 
 Euro USD 



















(248,585 - 3,480,191) 
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Table 5 Sensitivity analysis: total incremental health service costs attributable to diabetes 
Health service Direct costs, € 
(95% CI) 
 –20% +20% 





























A&E, accident and emergency department; GP, general practitioner. 
 
